CST3 and kidney disorder: The estimation GFR based on serum Cystatin C (eGFRcys) has been suggested to show better clinical utility for detecting nephropathy in patients with normoalbuminuria, as well as predicting the progression of nephropathy in patients with albuminuria (63).